We are live on
!
Find out more
CCMG
Connecticut Capital Management Group Portfolio holdings
AUM
$124M
This Fund
S&P 500
This Quarter
Est. Return
+17.7%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$18.3M
(+17%)
Cap. Flow
+$7.38M
Cap. Flow
% of AUM
5.95%
Top 10 Holdings %
Top 10 Hldgs %
42.22%
Holding
133
New
24
Increased
44
Reduced
38
Closed
4
Avg Time Held
1.5
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
1.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$359K |
| 2 |
Applovin
APP
|
+$353K |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$341K |
| 4 |
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
|
+$331K |
| 5 |
Arm
ARM
|
+$324K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$359K |
| 2 |
Netflix
NFLX
|
+$354K |
| 3 |
Chevron
CVX
|
+$280K |
| 4 |
Palantir
PLTR
|
+$254K |
| 5 |
White Mountains Insurance
WTM
|
+$207K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.25% |
| 2 | Technology | 21.05% |
| 3 | Industrials | 4.82% |
| 4 | Financials | 4.8% |
| 5 | Healthcare | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $259K | 0.21% |
2,680
| – | – |
2025 Q4
2 quarters
|
|
102
ZIM Integrated Shipping Services
ZIM
$3.49B
| $257K | 0.21% |
9,878
+285
| +3% | +$7.35K |
2025 Q4
2 quarters
|
|
103
Vanguard Intermediate-Term Treasury ETF
VGIT
$38.7B
| $255K | 0.21% |
4,329
+49
| +1% | +$2.9K |
2026 Q1
1 quarter
|
|
104
Gilead Sciences
GILD
$179B
| $251K | 0.2% |
1,988
+38
| +2% | +$5.01K |
2025 Q4
2 quarters
|
|
105
Royal Caribbean
RCL
$73.6B
| $251K | 0.2% |
790
-1
| -0.1% | -$280 |
2025 Q4
2 quarters
|
|
106
Philip Morris
PM
$295B
| $248K | 0.2% |
1,373
+3
| +0.2% | +$520 |
2025 Q4
2 quarters
|
|
107
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.6B
| $247K | 0.2% |
4,888
-95
| -2% | -$4.58K |
2025 Q4
2 quarters
|
|
108
Neurocrine Biosciences
NBIX
$14.7B
| $241K | 0.19% |
+1,432
| New | +$212K |
2026 Q2
0 quarters
|
|
109
Valero Energy
VLO
$121B
| $241K | 0.19% |
925
-4
| -0.4% | -$985 |
2026 Q1
1 quarter
|
|
110
Lockheed Martin
LMT
$117B
| $240K | 0.19% |
472
| – | – |
2025 Q4
2 quarters
|
|
111
Marriott International
MAR
$92.8B
| $238K | 0.19% |
643
| – | – |
2026 Q1
1 quarter
|
|
112
GE Vernova
GEV
$264B
| $237K | 0.19% |
+202
| New | +$206K |
2026 Q2
0 quarters
|
|
113
Kroger
KR
$34.7B
| $235K | 0.19% |
4,235
-25
| -0.6% | -$1.63K |
2025 Q4
2 quarters
|
|
|
AAUC
114
Allied Gold Corp
AAUC
$2.76B
| $233K | 0.19% |
+9,819
| New | +$278K |
2026 Q2
0 quarters
|
|
115
Amphenol
APH
$215B
| $231K | 0.19% |
+2,620
| New | +$189K |
2026 Q2
0 quarters
|
|
116
Dick's Sporting Goods
DKS
$13.5B
| $223K | 0.18% |
+983
| New | +$217K |
2026 Q2
0 quarters
|
|
117
Unity
U
$20.1B
| $221K | 0.18% |
+7,747
| New | +$206K |
2026 Q2
0 quarters
|
|
118
C.H. Robinson
CHRW
$16.4B
| $221K | 0.18% |
+1,174
| New | +$209K |
2026 Q2
0 quarters
|
|
119
Morgan Stanley
MS
$299B
| $220K | 0.18% |
+1,053
| New | +$209K |
2026 Q2
0 quarters
|
|
120
Boeing
BA
$152B
| $215K | 0.17% |
994
-11
| -1% | -$2.45K |
2025 Q4
2 quarters
|
|
121
Protagonist Therapeutics
PTGX
$9.1B
| $213K | 0.17% |
+1,736
| New | +$181K |
2026 Q2
0 quarters
|
|
122
SSR Mining
SSRM
$6.91B
| $211K | 0.17% |
7,471
+2
| +0% | +$61 |
2026 Q1
1 quarter
|
|
123
Parker-Hannifin
PH
$123B
| $210K | 0.17% |
+215
| New | +$197K |
2026 Q2
0 quarters
|
|
124
New York Times
NYT
$10.3B
| $208K | 0.17% |
2,968
| – | – |
2025 Q4
2 quarters
|
|
125
NextEra Energy
NEE
$159B
| $207K | 0.17% |
2,362
-18
| -0.8% | -$1.63K |
2026 Q1
1 quarter
|
|
Similar funds
PFG
CF
PHWM
OFS
BC
CF
RAM
SFP
Connecticut Capital Management Group's Q2 2026 Portfolio in Review
As of Q2 2026, Connecticut Capital Management Group held 133 positions worth $124M, up 17% from $106M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Connecticut Capital Management Group deployed $7.38M of net new capital in Q2 2026, opening 24 new positions and adding to 44 existing holdings. Its largest new stake was Boston Scientific: 6,618 shares worth $282K.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $359K trimmed.
- Connecticut Capital Management Group's largest Q2 2026 buy was Boston Scientific: 6,618 shares worth $282K.
- Connecticut Capital Management Group added most to iShares Core S&P Total US Stock Market ETF in Q2 2026, an estimated $341K increase.
- Connecticut Capital Management Group's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $359K.
- Connecticut Capital Management Group fully exited Netflix in Q2 2026, selling an estimated $354K.
- Connecticut Capital Management Group's ten largest holdings make up 42% of its $124M portfolio in Q2 2026.
- Connecticut Capital Management Group opened 24 new positions and closed 4 in Q2 2026.
- Connecticut Capital Management Group's portfolio value rose 17% quarter-over-quarter to $124M.
Based on Connecticut Capital Management Group's 13F filing for Q2 2026, filed 20 Jul 2026.